Zhang, Xiaoyu
Su, Kuan-Jui
Banerjee, Bodhisattwa
Eres, Ittai
Hsu, Yi-Hsiang
Crandall, Carolyn J.
Donaka, Rajashekar
Han, Zhe
Jackson, Rebecca D.
Liu, Hanhan
Luo, Zhe
Mitchell, Braxton D.
Qiu, Chuan
Tian, Qing
Shen, Hui
Tsai, Ming-Ju
Wiggins, Kerri L.
Xu, Hanfei
Yau, Michelle
Zhao, Lan-Juan
Zhang, Xiao
Montasser, May E.
Kiel, Douglas P.
Deng, Hong-Wen
Liu, Ching-Ti
Karasik, David https://orcid.org/0000-0002-8826-0530
Article History
Received: 28 April 2024
Accepted: 28 February 2025
First Online: 28 April 2025
Declarations
:
: All participants provided informed consent, and all studies were approved by the appropriate institutional review boards. Detailed ethics approval information, including the specific institutional review boards and approval statuses for the TOPMed and LOS cohorts, is provided in Additional file 1: SI 1 and SI 2, as well as Additional file 3: Table S2.
: All participants provided informed consent for publication.
: The authors declare no competing interests. Dr. Ittai Eres is employed by Amgen Inc and confirms that this employment did not influence the design, conduct, or reporting of this study. All other authors have no financial or non-financial interests that could be perceived as influencing the research reported in this manuscript. Dr. Douglas P. Kiel has received grants to his institution from Radius Health, Amgen, and Solarea Bio. He serves on a Data and Safety Monitoring Committee for Agnovos and has served on Scientific Advisory Boards for Radius Health and Solarea Bio. He receives royalties for publication in UpToDate by Wolters Kluwer.